iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET

Company Participants

Stephanie Zhadkevich - Director of Investor Relations

Quentin Blackford - President and Chief Executive Officer

Brice Bobzien - Chief Financial Officer

Douglas Devine - Chief Operating Officer

Daniel Wilson - Executive Vice President of Strategy and Corporate Development

Conference Call Participants

Margaret Kaczor - William Blair & Co. LLC

Allen Gong - JPMorgan Chase & Co.

Cecilia Furlong - Morgan Stanley

David Rescott - Truist Securities, Inc.

Joanne Wuensch - Citigroup Inc.

David Saxon - Needham & Company, LLC

William Plovanic - Canaccord Genuity Corp.

Suraj Kalia - Oppenheimer & Co. Inc.

Michael Polark - Wolfe Research, LLC

Operator

Hello, and welcome to today's iRhythm Technologies, Inc. Q3 2022 Earnings Conference Call. My name is Elliot, and I'll be coordinating your call today. [Operator Instructions]

I'd now like to hand over to Stephanie Zhadkevich, Director of Investor Relations. The floor is yours, please go ahead.

Stephanie Zhadkevich

Thank you all for participating in today's call. Earlier today, iRhythm released financial results for the third quarter ended September 30, 2022.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect management's intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance. These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.

Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission.

Also during the call, we will discuss certain financial measures that have not been prepared in accordance with U.S. GAAP with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses and adjusted net loss. Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of this additional information should not be considered in isolation of as a substitute for or superior to results prepared in accordance with GAAP. Please refer to the tables in our earnings release and 10-Q for a reconciliation of these measures to the most directly comparable GAAP financial measures.